Ardelyx (ARDX) Other Non Operating Income (2014 - 2019)
Ardelyx (ARDX) reported Other Non Operating Income of $294000.0 for Q3 2019, down 70.89% on a YoY basis from $1.0 million in Q3 2018, and down 63.79% quarter-over-quarter from $812000.0 in Q2 2019.
Ardelyx (ARDX) Other Non Operating Income (2014 - 2019) Analysis & Trends
Ardelyx has reported Other Non Operating Income for 6 years, with the latest figure at $294000.0 in Q3 2019.
- For the quarter ending Q3 2019, Other Non Operating Income fell 70.89% year-over-year to $294000.0; the trailing twelve-month figure through Sep 2019 stood at $2.9 million (up 6.14% YoY), and the FY2015 full-year result was -$261000.0, down 2710.0% from the prior year.
- Other Non Operating Income for Q3 2019 stood at $294000.0, down from $812000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.0 million in Q3 2018, with the low at -$123000.0 in Q4 2015.
- Historically, Other Non Operating Income has averaged $372071.4 across 5 years, with a median of $397500.0 in 2017.
- Annual changes were most pronounced in 2015 — Other Non Operating Income tumbled 1000.0% — and 2017, when it jumped 805.19%.
- Ardelyx's Other Non Operating Income stood at -$123000.0 in 2015, then jumped by 162.6% to $77000.0 in 2016, then surged by 550.65% to $501000.0 in 2017, then jumped by 101.6% to $1.0 million in 2018, then sank by 70.89% to $294000.0 in 2019.
- The last three Other Non Operating Income figures came in at $294000.0 (Q3 2019), $812000.0 (Q2 2019), and $790000.0 (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 294,000.00 |
| Jun 30, 2019 | 812,000.00 |
| Mar 31, 2019 | 790,000.00 |
| Sep 30, 2018 | 1.01 Mn |
| Jun 30, 2018 | 557,000.00 |
| Mar 31, 2018 | 670,000.00 |
| Sep 30, 2017 | 501,000.00 |
| Jun 30, 2017 | 697,000.00 |
| Jun 30, 2016 | 77,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | -123,000.00 |
| Sep 30, 2015 | -77,000.00 |
| Jun 30, 2015 | -49,000.00 |
| Mar 31, 2015 | -12,000.00 |
| Dec 31, 2014 | 29,000.00 |
| Sep 30, 2014 | -7,000.00 |
| Jun 30, 2014 | -8,000.00 |
| Mar 31, 2014 | -4,000.00 |